PROG

Progenity Stock Price

3.49
-0.03 (-0.85%)
Upgrade to Real-Time
Regular Market
3.49
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Progenity Inc PROG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.85% 3.49 15:12:58
Open Price Low Price High Price Close Price Prev Close
3.55 3.48 3.78 3.52
Bid Price Ask Price Spread News
3.49 3.54 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
979 289,063 $ 3.58 $ 1,034,786 1,300,305 3.08 - 15.90
Last Trade Time Type Quantity Stock Price Currency
15:19:58 100 $ 3.49 USD

Progenity Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 190.71M 54.65M 17.44M $ 143.99M $ - -5.49 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Progenity News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PROG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.614.653.453.85403,523-1.12-24.3%
1 Month4.715.133.454.45395,498-1.22-25.9%
3 Months6.367.863.455.44475,229-2.87-45.13%
6 Months9.339.483.085.17620,339-5.84-62.59%
1 Year15.1115.903.085.79429,203-11.62-76.9%
3 Years15.1115.903.085.79429,203-11.62-76.9%
5 Years15.1115.903.085.79429,203-11.62-76.9%

Progenity Description

Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.


Your Recent History
NASDAQ
PROG
Progenity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.